CONMED Quarterly Cash Flow Statement
NYSE: CNMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
44.42-0.69 (-1.53%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CONMED cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 23.07M | 16.74M | 2.86M | 21.42M | 6.04M | 33.76M | 48.98M | 29.98M | 19.71M | 33.07M | 15.84M | 13.73M |
| Net Income growth (YoY) | +282.22% | -50.41% | -94.16% | -28.54% | -69.37% | +2.07% | +209.30% | +118.29% | +983.51% | +24.40% | -65.68% | — |
| Depreciation & Amortization | — | 4.07M | 4.38M | 4.47M | 4.24M | 4.20M | 4.20M | 4.17M | 4.05M | 4.05M | 3.93M | 4.17M |
| Stock-Based Compensation | 5.23M | 4.97M | 4.58M | 4.90M | 13.86M | 6.22M | 6.12M | 6.97M | 6.24M | 5.92M | 6.19M | 6.42M |
| Change in Working Capital | — | -21.39M | 13.27M | -26.51M | 8.82M | -28.92M | -4.70M | -11.31M | 8.24M | 635.00K | -3.90M | -18.42M |
| Operating Cash Flow | — | 46.34M | 53.69M | 29.13M | 41.53M | 43.34M | 51.20M | 43.31M | 29.12M | 56.40M | 46.13M | 26.67M |
| Capital Expenditures | — | -5.11M | -5.19M | -5.73M | -3.78M | -4.04M | -3.42M | -3.59M | -2.04M | -4.86M | -5.39M | -4.53M |
| Investing Cash Flow | — | -7.11M | -5.19M | -5.73M | -2.93M | -4.04M | -3.42M | -3.59M | -2.04M | -4.86M | -5.39M | -5.53M |
| Dividends Paid | — | -6.19M | -6.19M | -6.19M | -6.18M | -6.18M | -6.16M | -6.16M | -6.15M | -6.15M | -6.14M | -6.11M |
| Debt Issued | — | 0 | 0 | — | — | 0 | 0 | — | — | — | — | — |
| Debt Repaid | — | -20.00M | -25.00M | -40.23M | -14.59M | 0 | 0 | 0 | 0 | -20.00M | 0 | 0 |
| Financing Cash Flow | — | -37.37M | -43.52M | -26.53M | -28.40M | -51.07M | -38.83M | -44.09M | -17.01M | -58.77M | -37.23M | -19.79M |
| Net Change in Cash | — | 1.89M | 4.99M | -1.55M | 11.03M | -14.01M | 9.60M | -4.99M | 9.56M | -6.21M | 2.65M | 1.35M |
| Free Cash Flow | — | 41.22M | 48.50M | 23.41M | 37.76M | 39.30M | 47.78M | 39.72M | 27.09M | 51.54M | 40.73M | 22.14M |
This table shows 12 quarterly periods of CONMED's cash flow statement, from Q2 2026 back to Q2 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CNMD's reporting calendar. What is a cash flow statement?